{"id":203874,"date":"2026-08-14T12:18:32","date_gmt":"2026-08-14T06:48:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=203874"},"modified":"2026-08-14T12:18:32","modified_gmt":"2026-08-14T06:48:32","slug":"why-marksans-pharma-ltd-share-price-52-week-high-2026-08-14","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-08-14\/","title":{"rendered":"Marksans Pharma Ltd. (MARKSANS) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma Ltd.<\/a> Share Price rose to Rs 317.60, up 4.75% today, after hitting a fresh 52-week high of Rs 321.85. The company\u2019s market capitalisation stood at Rs 14,172.70 crore.<\/p>\n<p style=\"margin-top:0!important;\">Marksans Pharma Ltd. Share Price moved up to Rs 317.60 on 14 August 2026, gaining Rs 14.40 or 4.75% over the previous close of Rs 303.20, after touching a fresh 52-week high of Rs 321.85. With market capitalisation at Rs 14,172.70 crore, the move has pushed the stock into focus across Stock Market Today screens, 52 Week High Stocks lists and broader Market News trackers.<\/p>\n<p>The supplied data confirms the price event clearly: the stock opened at Rs 301.95, traded between Rs 300.50 and Rs 321.85, and recorded turnover of Rs 13.54 crore with volume of 4,26,328 shares. That combination makes the one-year high relevant because it reflects both price expansion and active trading participation during the session.<\/p>\n<p>For investors searching Marksans Pharma Ltd. Share Price Today, Marksans Pharma Ltd. Stock News or Why Is Marksans Pharma Ltd. Rising Today, the verified data establishes the fresh 52-week high but does not establish a company-specific catalyst. What investors can evaluate immediately, however, is the price action, the valuation profile, the profitability ratios and how the company compares with Healthcare sector benchmarks and listed peers. That is where Univest analysis becomes useful, especially when a stock appears among Market Movers and Stocks in News without a confirmed trigger.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Marksans Pharma Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 317.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 303.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 14.4 (+4.75%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 301.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 321.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 300.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,26,328<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13.54 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,172.7 crore<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) traded at Rs 317.6. versus the previous close of Rs 303.2, a rise of 4.75%. The stock opened at Rs 301.95, reached Rs 321.85, touched Rs 300.5. Reported volume was 4,26,328.<\/p>\n<p>Marksans Pharma Ltd. Share Price Today reflects a strong session in pure price terms, with the stock rising 4.75%, moving from a previous close of Rs 303.20 to Rs 317.60 and touching a fresh 52-week peak of Rs 321.85. The intraday range, turnover and volume show that the one-year high was not a marginal tick but part of an active trading session.<\/p>\n<p>The stock opened at Rs 301.95, slightly below the previous close of Rs 303.20, and then expanded sharply through the day. It went on to hit a day high of Rs 321.85, which also became the new yearly high, before trading at Rs 317.60 at the time of the event. The day low was Rs 300.50, which means the stock travelled Rs 21.35 from low to high during the session.<\/p>\n<p>That intraday range matters for Marksans Pharma Ltd. Share Price because it shows the move was broad enough to attract attention in Share Market Today discussions and intraday Stock Updates. The turnover of Rs 13.54 crore and volume of 4,26,328 shares indicate meaningful market participation alongside the fresh 52-week high. For traders watching Price Action and possible Technical Breakout setups, the stock\u2019s ability to print a new 52-week peak while holding well above the opening level is the central verified takeaway from today\u2019s tape.<\/p>\n<p>At the same time, the data does not assign a catalyst. So, the immediate next step is not speculation, but a closer look at whether the current valuation and business-return ratios support the attention Marksans Pharma Ltd. Share Price is receiving.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Ltd_MARKSANS_Fundamental_Analysis\"><\/span><strong>Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,172.7 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. was valued at a P\/E ratio of 31.94x, a P\/B ratio of 0.47x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,299.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,172.7 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 141.55 crore<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) is classified under sector: Healthcare.<\/p>\n<p>Marksans Pharma Ltd. (MARKSANS) has a P\/E ratio of 31.94x, which is above the benchmark median of 21.38x, a difference of +49.39%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Marksans Pharma Ltd. (MARKSANS) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Marksans Pharma Ltd. (MARKSANS) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,995.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,836.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">69.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,644.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,605.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,441.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">174.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) has a P\/E ratio of 31.94x compared with the displayed peer median of 45.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Marksans Pharma Ltd. (MARKSANS) has a market capitalisation of Rs 14,172.7 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Marksans_Pharma_Ltd\"><\/span><strong>Why Investors Are Watching Marksans Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The fresh one-year high has put the stock firmly on investor watchlists. Based on verified data from Univest, here are the main reasons Marksans Pharma Ltd. Share Price is attracting attention today.<\/p>\n<ul>\n<li><strong>Fresh 52-week high:<\/strong> the stock touched Rs 321.85 and was trading at Rs 317.60, up 4.75% on the day.<\/li>\n<li><strong>Active session:<\/strong> turnover stood at Rs 13.54 crore with 4,26,328 shares traded, showing meaningful participation.<\/li>\n<li><strong>Large listed size:<\/strong> market capitalisation of Rs 14,172.70 crore makes it a notable Healthcare counter in Market Trends screens.<\/li>\n<li><strong>Valuation mix:<\/strong> P\/E is 31.94 and P\/B is 0.47, a combination that invites closer Financial Analysis.<\/li>\n<li><strong>Profitability watch:<\/strong> ROE of -2.89% and ROCE of -0.26% sit below supplied sector medians.<\/li>\n<li><strong>Relative positioning:<\/strong> compared with supplied peers, the company combines low P\/B and high size with weaker return ratios.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Marksans_Pharma_Ltd\"><\/span><strong>About Marksans Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Marksans Pharma Ltd. is part of the Healthcare sector, and the supplied peer set places it alongside companies in Pharmaceuticals &amp; Drugs as well as wider Healthcare businesses. In market classification terms, it is being compared with pharmaceutical and healthcare names such as Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories and Dr Agarwals Eye Hospital.<\/p>\n<p>That matters because investors looking at Marksans Pharma Ltd. Company News or Marksans Pharma Ltd. Share News are not only tracking today\u2019s 52-week high, but also how the company sits within the broader Healthcare investable universe. The current sector benchmark used here covers 196 companies, which gives a wide context for comparing valuation and return ratios. Based on the supplied data, Marksans Pharma Ltd. is a large-capitalisation name within that benchmark set, even though the current return metrics in this dataset are negative.<\/p>\n<p>In practical terms, the company is best understood here through its market position in listed Healthcare screens, its current valuation ratios and its movement to a fresh yearly high. That is the verified operating context available for this Marksans Pharma Ltd. Stock Analysis.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Marksans_Pharma_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Marksans Pharma Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma Ltd. (MARKSANS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors who want to follow Marksans Pharma Ltd. Share Price Live can track the stock on Univest for real-time price moves, 52-week levels, market-cap changes, valuation ratios and broader market insights. Univest also helps users compare Marksans Pharma Ltd. Share Price Today with peer valuation data and sector benchmarks in a single view.<\/p>\n<p>For those monitoring Marksans Pharma Ltd. Latest News, Marksans Pharma Ltd. NSE coverage, Marksans Pharma Ltd. BSE visibility or a broader Share Price Update, Univest provides a structured way to follow fresh 52-week highs without turning them into unsupported conclusions. When a stock appears in Top Gainers Today, Breakout Stocks or Momentum Stocks lists, the key is to pair price action with fundamentals and peer context.<\/p>\n<p>That is especially relevant here because the supplied data confirms a strong market move, but investors will still want to monitor how valuation, profitability and sector-relative metrics evolve after the stock\u2019s new 52-week peak.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Marksans_Pharma_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Marksans Pharma Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma Ltd. Share Price Today was Rs 317.60 at the time of the event. The stock was up Rs 14.40, or 4.75%, from the previous close of Rs 303.20 during the 14 August 2026 session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Marksans_Pharma_Ltd_hit_a_fresh_52-week_high_today\"><\/span><strong>Did Marksans Pharma Ltd. hit a fresh 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Marksans Pharma Ltd. hit a fresh 52-week high of Rs 321.85 on 14 August 2026. The stock later traded at Rs 317.60, keeping the counter in focus across intraday stock news and market movers screens.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Marksans_Pharma_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Marksans Pharma Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that the stock rose 4.75% and touched a new one-year high, but it does not establish a company-specific catalyst. Verified attention comes from the price move, turnover of Rs 13.54 crore and fresh 52-week peak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_Marksans_Pharma_Ltd_today\"><\/span><strong>What was the intraday range for Marksans Pharma Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma Ltd. traded between Rs 300.50 and Rs 321.85 during the session. It opened at Rs 301.95, crossed the previous close of Rs 303.20 and climbed to a fresh yearly high before easing slightly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Marksans_Pharma_Ltd\"><\/span><strong>What is the market capitalisation of Marksans Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Marksans Pharma Ltd. stood at Rs 14,172.70 crore in the supplied data. That places it far above the Healthcare sector benchmark median market cap of Rs 141.55 crore shown in the comparison set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Marksans_Pharma_Ltd_expensive_based_on_PE_ratio\"><\/span><strong>Is Marksans Pharma Ltd. expensive based on P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma Ltd. trades at a P\/E ratio of 31.94. That is above the supplied Healthcare sector median of 21.38 but below the sector average of 59.96, so the valuation sits above median without being near benchmark extremes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_PB_ratio_of_Marksans_Pharma_Ltd_indicate\"><\/span><strong>What does the P\/B ratio of Marksans Pharma Ltd. indicate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied P\/B ratio is 0.47 for Marksans Pharma Ltd. This is below the Healthcare sector median of 1.95 and average of 2.63, showing the stock trades at a relatively low price-to-book multiple versus the benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Marksans_Pharma_Ltd_based_on_ROE_and_ROCE\"><\/span><strong>How profitable is Marksans Pharma Ltd. based on ROE and ROCE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied profitability ratios are weak, with ROE at -2.89% and ROCE at -0.26%. Both figures are below the Healthcare sector median levels of 10.92% for ROE and 13.29% for ROCE in the benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Marksans_Pharma_Ltd_compare_with_peers\"><\/span><strong>How does Marksans Pharma Ltd. compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Compared with supplied peers, Marksans Pharma Ltd. has a lower P\/B ratio at 0.47 and a larger market cap of Rs 14,172.70 crore, but its ROE of -2.89% and ROCE of -0.26% trail peers with positive return ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_investors_track_Marksans_Pharma_Ltd_Share_Price_live\"><\/span><strong>Where can investors track Marksans Pharma Ltd. Share Price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track Marksans Pharma Ltd. Share Price live on Univest for price updates, 52-week levels, market capitalisation, valuation ratios and sector comparisons. That helps place daily stock moves in a broader analytical context.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marksans Pharma Ltd. Share Price hits a new 52-week high at Rs 317.6. marking a 4.75% rise today. Market cap stands at Rs 14,172.7 crore.<\/p>\n","protected":false},"author":29,"featured_media":203873,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-203874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["203873"],"rank_math_title":["Marksans Pharma Ltd. Share Price Today: New 52-Week High"],"rank_math_description":["Marksans Pharma Ltd. Share Price touched a new 52-week high. Check today\u2019s move, market cap, valuation metrics and Healthcare sector comparison."],"rank_math_focus_keyword":["Marksans Pharma Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Marksans_Pharma_Ltd_MARKSANS_Share_Price_Hits_Fresh_52_Week_High_bullish-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/203874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=203874"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/203874\/revisions"}],"predecessor-version":[{"id":203875,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/203874\/revisions\/203875"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/203873"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=203874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=203874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=203874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}